Home/Filings/4/0001837830-23-000001
4//SEC Filing

McClurg Ronald W. 4

Accession 0001837830-23-000001

CIK 0001500198other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 3:39 PM ET

Size

7.4 KB

Accession

0001837830-23-000001

Insider Transaction Report

Form 4
Period: 2023-04-21
McClurg Ronald W.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-04-21+12,50079,500 total
  • Award

    Option to Purchase Common Stock

    2023-04-21+12,50012,500 total
    Exercise: $1.59Exp: 2033-04-20Common Stock (12,500 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest as to 50% of the shares on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments on the last day of each quarter over the next 8 quarters, subject to continued service on such vesting date.
  • [F2]25% will vest on April 21, 2024 and the remaining 75% will vest in 12 equal quarterly installments on the last day of each quarter beginning on June 30, 2024.

Issuer

NEUROONE MEDICAL TECHNOLOGIES Corp

CIK 0001500198

Entity typeother

Related Parties

1
  • filerCIK 0001837830

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 3:39 PM ET
Size
7.4 KB